1. MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies
   Xiaoyang Ye et al, 2015, Front. Aging Neurosci. CrossRef
2. Combined Application of Phosphoinositide 3-Kinase and Mammalian Target of Rapamycin Inhibitors Suppresses Cell Growth and Promotes Apoptosis in Human Lung Cancer Cell Lines
   Marzieh Badinloo et al, 2016, Iran J Cancer Prev CrossRef
3. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway
   XIANGLIANG ZHANG et al, 2015 CrossRef
4. mTOR Cross-Talk in Cancer and Potential for Combination Therapy
   Fabiana Conciatori et al, 2018, Cancers CrossRef
5. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway
   Lin Wang et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
6. Isothermal Self-Assembly of Spermidine–DNA Nanostructure Complex as a Functional Platform for Cancer Therapy
   Dong Wang et al, 2018, ACS Appl. Mater. Interfaces CrossRef
7. miR-149 regulates the proliferation and apoptosis of cervical cancer cells by targeting GIT1
   Bing Qian et al, 2018, Biomedicine & Pharmacotherapy CrossRef
8. Comparison of PI3K pathway in HPV-associated oropharyngeal cancer with and without tobacco exposure
   Si-Young Kiessling et al, 2018, Laryngoscope Investigative Otolaryngology CrossRef
9. Expression of the phosphorylated variant of the AKT1-kinase (p-AKT1) in well-differentiated pancreatic neuroendocrine tumors: immunohistochemical evaluation
   V. V. Delektorskaya et al, 2018, Alʹm. klin. med. CrossRef
10. null
    Nathaniel Robichaud et al, 2014 CrossRef
11. null
    Armen Parsyan et al, 2014 CrossRef
12. null
    Kerstin A. David et al, 2015 CrossRef
13. The evolving genomic classification of lung cancer
    David S Shames et al, 2014, J. Pathol. CrossRef
14. Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis
    Qiu Zhao et al, 2014, Future Oncology CrossRef
15. Use of mTOR inhibitors in the treatment of malignancies
    Nisha A Mohindra et al, 2014, Expert Opinion on Pharmacotherapy CrossRef
16. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
    Chen Wang et al, 2014, Eur J Pharmacol CrossRef
17. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors
    Yan-Yan Wang et al, 2014, Anti-Cancer Drugs CrossRef
18. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma
    Konstantia E. Tasioudi et al, 2015, APMIS CrossRef
19. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
    Yanchun Liu et al, 2015, PLoS ONE CrossRef
20. Clinical Efficacy and Possible Applications of Genomics in Lung Cancer
    Khalid Khalaf Alharbi, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
21. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer
    Mee Sook Roh et al, 2015, Virchows Arch CrossRef
22. The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer
    Maria L. Karadima et al, 2016, Pathol. Oncol. Res. CrossRef
23. Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma
    Ildikó Krencz et al, 2017, Human Pathology CrossRef
24. Eukaryotic translation initiation factors and cancer
    Muhammad Umar Ali et al, 2017, Tumour Biol. CrossRef
25. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway
    Yingyi Wang et al, 2017 CrossRef
26. Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway
    Anthony Adimonye et al, 2018, Oncotarget CrossRef
27. Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
    Tomotaka Shimura et al, 2018, Oncotarget CrossRef
28. Targeting Notch to overcome radiation resistance
    Sanaz Yahyanejad et al, 2016, Oncotarget CrossRef
29. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma
    Longmei Cai et al, 2015, Oncotarget CrossRef
30. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer
    Tangfeng Lv et al, 2015, Oncotarget CrossRef
31. Potential of AKT2 expression as a predictor of lymph-node metastasis in invasive breast carcinoma of no special type
    Primariadewi Rustamadji et al, 2021, J Pathol Transl Med CrossRef
32. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer
    Venkatasubbaiah A Venkatesha et al, 2014, Mol Cancer CrossRef
33. Etomidate inhibits cell proliferation and induces apoptosis in A549 non‑small cell lung cancer cells via downregulating WWP2
    Deqiang Li et al, 2021, Exp Ther Med CrossRef
34. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway
    Li Yang et al, 2020, Life Sciences CrossRef